S. Chaboz

Trace amine-associated receptor 1 activation silences GSK3β signaling of TAAR1 and D2R heteromers

G. Dernick, B. Bettler, A. Harmeier, 2015, European Neuropsychopharmacology.

In Vitro Characterization of Psychoactive Substances at Rat, Mouse, and Human Trace Amine-Associated Receptor 1

M. Liechti, M. Hoener, L. Simmler, 2016, The Journal of Pharmacology and Experimental Therapeutics.

Pharmacological characterization of designer cathinones in vitro

M. Liechti, M. Donzelli, M. Hoener, 2013, British journal of pharmacology.

Characterization of [3H]‐(2S,2′R,3′R)‐2‐(2′,3′‐dicarboxy‐ cyclopropyl)glycine ([3H]‐DCG IV) binding to metabotropic mGlu2 receptor‐transfected cell membranes

F. Monsma, J. Kemp, G. Adam, 1998, British journal of pharmacology.

Characterization of [3H]Quisqualate Binding to Recombinant Rat Metabotropic Glutamate 1a and 5a Receptors and to Rat and Human Brain Sections

R. Faull, G. Adam, P. Malherbe, 2000, Journal of neurochemistry.

Characterization of (2S,2′R,3′R)‐2‐(2′,3′‐[3H]‐Dicarboxycyclopropyl)glycine Binding in Rat Brain

J. Kemp, T. Woltering, G. Adam, 1998, Journal of neurochemistry.

In vitro binding characteristics of a new selective group II metabotropic glutamate receptor radioligand, [3H]LY354740, in rat brain.

J. Kemp, T. Woltering, V. Mutel, 1998, Molecular pharmacology.

A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight

Stephen R. Morairty, A. Bruns, C. Risterucci, 2013, Molecular Psychiatry.

TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity

T. Sotnikova, R. Gainetdinov, M. Caron, 2011, Proceedings of the National Academy of Sciences.